Assignee
STEALTH BIOTHERAPEUTICS CORP
MC·32 granted patents·44 pending applications·131 citations·filing 2013–2021
Top patents by PatentIndex Score
76 records- 0197US11034724B2Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted Jun 15, 2021·5 cites·14 claims
- 0296US11083772B2Methods and compositions for the prevention or treatment of Barth SyndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·5 cites·15 claims
- 0396US9549963B2Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Jan 24, 2017·17 cites·9 claims
- 0495US10188692B2Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jan 29, 2019·8 cites·9 claims
- 0594US10835573B2Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levelsSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Nov 17, 2020·4 cites·9 claims
- 0694US10047395B2Methods and compositions for detecting and diagnosing diseases and conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Aug 14, 2018·10 cites·8 claims
- 0793US10683326B2Crystalline salt formsSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jun 16, 2020·6 cites·15 claims
- 0893US10676506B2Crystalline bis- and tris-hydrochloride salt of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Jun 9, 2020·6 cites·19 claims
- 0993US10576124B2Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereofSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Mar 3, 2020·6 cites·6 claims
- 1092US10744178B2Methods and compositions for the prevention and treatment of diseaseSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Aug 18, 2020·4 cites·9 claims
- 1191US10975118B2Crystalline dipeptides useful in the synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Apr 13, 2021·4 cites·4 claims
- 1291US10293020B2Peptide therapeutics and methods for using sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted May 21, 2019·7 cites·5 claims
- 1391US10188693B2Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2013·Granted Jan 29, 2019·6 cites·6 claims
- 1489US11083771B2Methods and compositions for the prevention or treatment of Barth SyndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Aug 10, 2021·5 cites·18 claims
- 1589US9687519B2Methods and compositions for the prevention or treatment of barth syndromeSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Jun 27, 2017·8 cites·6 claims
- 1688US10961273B2N-carboxyanhydride-based-scale synthesis of elamipretideSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Mar 30, 2021·4 cites·20 claims
- 1788US10702577B2Combination therapies using cyclosporine and aromatic cationic peptidesSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted Jul 7, 2020·2 cites·14 claims
- 1887US10793597B2Methods for the treatment of mitochondrial diseases associated with a mutation in SURF 1 or POLG gene resulting in a disruption of mitochondrial oxidative phosphorylationSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Oct 6, 2020·7 cites·6 claims
- 1987US10221213B2Pharmaceutically relevant aromatic-cationic peptidesSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Mar 5, 2019·5 cites·17 claims
- 2085US10627392B2Methods of identifying and monitoring mitochondrial dysfunction using monocyte screeningSTEALTH BIOTHERAPEUTICS CORP·Filed 2015·Granted Apr 21, 2020·2 cites·20 claims
- 2184US11141456B2Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereofSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Granted Oct 12, 2021·1 cites·12 claims
- 2283US9877997B2Methods and compositions for regulating SRCA2A expression levels in myocardial infarctionSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Jan 30, 2018·2 cites·10 claims
- 2380US11325943B2Crystalline salt forms of SBT-20STEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted May 10, 2022·1 cites·14 claims
- 2480US10646539B2Methods and compositions for the treatment of neuropathy and hyperalgesiaSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 2578US10279008B2Methods and compositions for increasing the dose of a chemotherapeutic agentSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Granted May 7, 2019·1 cites·9 claims
- 2676US9884085B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Granted Feb 6, 2018·2 cites·18 claims
- 2776US2020407396A1Methods for the treatment of mitochondrial diseaseSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2876US2020360462A1Methods for reducing risks associated with heart failure and factors associated therewithSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 2975US11266709B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Granted Mar 8, 2022·0 cites·12 claims
- 3075US10525098B2Methods for the regulation of matrix metalloproteinase expressionSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Granted Jan 7, 2020·1 cites·18 claims
- 3174US2020061147A1Methods and compositions for preventing or treating ophthalmic conditionsSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 3274US2021130402A1Aromatic-cationic peptides and uses of sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3372US2021401925A1Methods and compositions for preventing or treating dominant optic atrophySTEALTH BIOTHERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 3472US2016193278A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 3571US2019365846A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 3671US2020000870A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 3770US2019358286A1Methods for the prevention or treatment of left ventricle remodelingSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 3870US2020397850A1Methods and compositions for the prevention and treatment neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3969US2018207225A1Methods and compositions for the prevention and treatment of friedreich's ataxiaSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4068US10322159B2Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injurySTEALTH BIOTHERAPEUTICS CORP·Filed 2016·Granted Jun 18, 2019·1 cites·11 claims
- 4168US2020113966A1Methods and compositions for regulating srca2a expression levels in myocardial infarctionSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 4268US2018339012A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4368US2021046146A1Methods for performing a coronary artery bypass graft procedureSTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4468US2021038677A1Methods and compositions for preventing or treating leber's hereditary optic neuropathySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4568US2021023160A1Methods for the prevention or treatment of vessel occlusion injurySTEALTH BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4667US2018344797A1Methods for treatment of atherosclerosisSTEALTH BIOTHERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 4767US2016256514A1Methods for the prevention or treatment of left ventricle remodelingSTEALTH BIOTHERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 4865US2019106458A1Aromatic-cationic peptides and uses of sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 4964US2019374596A1Peptide therapeutics and methods for using sameSTEALTH BIOTHERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 5063US2019365845A1Methods for performing a coronary artery bypass graft procedureSTEALTH BIOTHERAPEUTICS CORP·Filed 2018·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →